NEW YORK (GenomeWeb News) — Biomatrica said today that it has signed a worldwide distribution agreement with Sigma-Aldrich for its biomolecule stabilization products.

Under the agreement, Sigma-Aldrich has non-exclusive rights to distribute Biomatrica's products, which allow scientists to collect, stabilize, store, and ship biological samples such as purified DNA and RNA, as well as more complex specimens such as cells and tissues, at ambient temperatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.